These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3387499)
21. Dopamine turnover in schizophrenia before and after haloperidol withdrawal. CSF, plasma, and urine studies. Beuger M; van Kammen DP; Kelley ME; Yao J Neuropsychopharmacology; 1996 Jul; 15(1):75-86. PubMed ID: 8797194 [TBL] [Abstract][Full Text] [Related]
22. Differential effects of haloperidol on negative symptoms in drug-naive schizophrenic patients: effects on plasma homovanillic acid. Labarca R; Silva H; Jerez S; Ruiz A; Forray MI; Gysling K; Andres ME; Bustos G; Castillo Y; Hono J Schizophr Res; 1993 Mar; 9(1):29-34. PubMed ID: 8461269 [TBL] [Abstract][Full Text] [Related]
23. Differential effect of haloperidol and clozapine on plasma homovanillic acid in elderly schizophrenic patients with or without tardive dyskinesia. Andia I; Zumarraga M; Zabalo MJ; Bulbena A; Davila R Biol Psychiatry; 1998 Jan; 43(1):20-3. PubMed ID: 9442340 [TBL] [Abstract][Full Text] [Related]
24. Schizophrenia: gender, family risk, and plasma homovanillic acid. Dávila R; Zumárraga M; González-Torres MA; Andía I; Zamalloa MI; Basterreche E; Guimón J; Friedhoff AJ Am J Med Genet; 1995 Apr; 60(2):154-6. PubMed ID: 7485251 [TBL] [Abstract][Full Text] [Related]
25. Correlates of rapid neuroleptic response in male patients with schizophrenia. Petrie EC; Faustman WO; Moses JA; Lombrozo L; Csernansky JG Psychiatry Res; 1990 Aug; 33(2):171-7. PubMed ID: 2243894 [TBL] [Abstract][Full Text] [Related]
26. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis. Mazure CM; Nelson JC; Jatlow PI; Bowers MB Biol Psychiatry; 1991 Sep; 30(5):475-82. PubMed ID: 1932395 [TBL] [Abstract][Full Text] [Related]
27. Apomorphine has no effect on plasma homovanillic acid in schizophrenic patients. Davidson M; Kendler KS; Davis BM; Horvath TB; Mohs RC; Davis KL Psychiatry Res; 1985 Oct; 16(2):95-9. PubMed ID: 3865258 [TBL] [Abstract][Full Text] [Related]
28. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment. Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208 [TBL] [Abstract][Full Text] [Related]
29. Free and conjugated plasma homovanillic acid in schizophrenic patients. Garcia A; Galinowski A; Guicheney P; Mignot E; Loo H; Meyer P Biol Psychiatry; 1989 May; 26(1):87-96. PubMed ID: 2720023 [TBL] [Abstract][Full Text] [Related]
30. Interconversions between haloperidol and reduced haloperidol in schizophrenic patients and guinea pigs: a steady-state study. Chang WH; Lin SK; Jann MW J Clin Psychopharmacol; 1991 Apr; 11(2):99-105. PubMed ID: 2056148 [TBL] [Abstract][Full Text] [Related]
31. Studies of catecholamine metabolism in schizophrenia/psychosis--II. Maas JW; Contreras SA; Miller AL; Berman N; Bowden CL; Javors MA; Seleshi E; Weintraub SE Neuropsychopharmacology; 1993 Feb; 8(2):111-6. PubMed ID: 8471122 [TBL] [Abstract][Full Text] [Related]
32. Effect of trifluoperazine on CSF and plasma HVA levels in schizophrenic subjects. Sharma R; Javaid JI; Janicak P; Comaty J; Davis JM; Faull K Am J Psychiatry; 1988 Nov; 145(11):1480-1. PubMed ID: 3189613 [No Abstract] [Full Text] [Related]
33. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation. Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618 [TBL] [Abstract][Full Text] [Related]
34. Acute effects of neuroleptics on unmedicated schizophrenic patients and controls. Miller AL; Maas JW; Contreras S; Seleshi E; True JE; Bowden C; Castiglioni J Biol Psychiatry; 1993 Aug; 34(3):178-87. PubMed ID: 8104509 [TBL] [Abstract][Full Text] [Related]
36. Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients. Kirch DG; Jaskiw G; Linnoila M; Weinberger DR; Wyatt RJ Psychiatry Res; 1988 Sep; 25(3):233-42. PubMed ID: 2903509 [TBL] [Abstract][Full Text] [Related]
37. Longitudinal changes in symptoms and plasma homovanillic acid levels in chronically medicated schizophrenic patients. Suzuki E; Kanba S; Nibuya M; Adachi S; Sekiya U; Shintani F; Kinoshita N; Yagi G; Asai M Biol Psychiatry; 1994 Nov; 36(10):654-61. PubMed ID: 7880934 [TBL] [Abstract][Full Text] [Related]
38. Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol. Brown AS; Gewirtz G; Harkavy-Friedman J; Cooper T; Brébion G; Amador XF; Malaspina D; Gorman JM Neuropsychopharmacology; 1997 Nov; 17(5):317-25. PubMed ID: 9348547 [TBL] [Abstract][Full Text] [Related]
39. Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations. Suzuki E; Kanba S; Koshikawa H; Nibuya M; Yagi G; Asai M J Psychiatry Neurosci; 1996 May; 21(3):167-71. PubMed ID: 8935328 [TBL] [Abstract][Full Text] [Related]